LEADER 01325nam2-2200409---450 
001 996572272703316
005 20240124091220.0
010   $a978-012-8206676
035   $a000609319
035   $aUSA01000609319
035   $a(ALEPH)000609319USA01
035   $a000609319
100   $a20090918h2020----km-y0itay50------ba
101   $aeng
102   $aUS
105   $aaf--||||001yy
200 1 $aTumor immunology and immunotherapy$eintegrated methods Part A$fedited by Lorenzo Galluzzi, Nils-Petter Rudqvist
210   $aCambridge [MA]$cAcademic Press$d2020
215   $aXXXVIII, 305 p.$cill.$d24 cm
225 2 $aMethods in enzymology$v635
410  0$1001990002876030203316$12001$aMethods in enzymology$v635
606 0 $aTumori$xImmunoterapia$2BNCF
676   $a615.37
702  1$aGALLUZZI,$bLorenzo
702  1$aRUDQUIST,$bNils-Petter
801  0$aIT$bsalbc$gISBD
912   $a996572272703316
951   $a572.7 MET/635$b6455 Farm.$c572$d544446
959   $aBK
969   $aFAR
979   $aPAOLA$b90$c20151028$lUSA01$h1542
979   $aPAOLA$b90$c20151028$lUSA01$h1543
979   $aPAOLA$b90$c20151028$lUSA01$h1545
979   $aPAOLA$b90$c20151028$lUSA01$h1621
979   $aPAOLA$b90$c20151221$lUSA01$h1640
996   $aTumor Immunology and Immunotherapy$91568163
997   $aUNISA